Why CME Group Inc. (CME) stock moved
CME Group Inc. (CME) shares rose 1.7% to $285.80 as of August 30, 2026, a modest gain from the prior close of $280.94. BestStocks flagged the session as a major change for CME. The move is tied to price move up. Below, we break down what changed for CME, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
CME climbed 1.7% to $285.80
CME Group Inc. (CME) moved +1.64% from $281.20 to $285.80 on 2026-08-28. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears to be driven by technical factors: CME reached a new 30-day high with volume 1.6x the 5-day average. Monitor CME's earnings announcement on 2026-10-28 for confirmation of fundamental health and any forward guidance.
What it means for CME Group Inc. investors
For CME Group Inc. investors, the balance of recent signals points to a bullish shift. On the constructive side: Material positive event; Positive 1.7% session move. Weighing against that: CME Group Inc. (CME) moved -3.15% from $245.11 to $237.38 on 2026-07-21; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $299.00, implying +4.6% upside from $285.80. Over the past 90 days analysts logged 2 upgrades and 2 downgrades. BestStocks rates the overall signal quality weak (34/100). With earnings roughly 59 days out, the next report is the most likely near-term test of the move.
CME price reaction
CME last traded at $285.80, up $4.86 (+1.73%) from the previous close of $280.94. The session traded on 0.9× average volume (below avg), so participation was unremarkable.
Bullish and bearish analyst opinions on CME Group Inc. (CME)
The consensus analyst price target on CME Group Inc. (CME) is $299.00, 4.6% above the recent $285.80. Over the past 90 days analysts logged 2 upgrades, 10 maintains, and 2 downgrades. Here is how the bullish and bearish cases on CME line up.
The bullish case
- Wall Street's consensus price target of $299.00 implies +4.6% upside from $285.80.
- The Street's most bullish target is $330.00 (+15.5%).
- 2 analyst upgrades in the past 90 days, most recently Keefe, Bruyette & Woods to Outperform (2026-06-18).
- Material positive event.
- Positive 1.7% session move.
The bearish case
- The most bearish analyst target is $260.00 (-9.0%).
- 2 analyst downgrades in the past 90 days, most recently Deutsche Bank to Hold (2026-08-19).
- CME Group Inc. (CME) moved -3.15% from $245.11 to $237.38 on 2026-07-21.
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Aug 30, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for CME
Frequently asked questions about CME
Why did CME Group Inc. (CME) stock move?
CME rose 1.7% to $285.80. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did CME stock rise?
CME gained 1.73% ($4.86) versus the prior close of $280.94, last trading at $285.80 on 0.9× average volume.
When is CME Group Inc.'s next earnings date?
CME's next earnings report is estimated for 2026-10-28 — about 59 days away.
What is the analyst price target for CME?
The consensus analyst price target for CME is $299.00, about 4.6% above the current $285.80. Over the past 90 days, analysts recorded 2 upgrades, 10 maintains, and 2 downgrades.
How BestStocks tracks CME
This page is generated automatically by BestStocks' change-detection system after price move up was detected and verified against independent data sources. It draws on 20 tracked change events for CME, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 30, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.